Takeaway
- For patients with type 2 diabetes (T2D) who cannot take metformin, a meta-analysis suggests glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be the best overall first-line alternative based on efficacy and safety, but other agents may better meet individual needs.
Why this matters
- Clinical guidelines for T2D recommend metformin as...
